EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Extracellular Vesicles and Immune Activation in Solid Organ Transplantation: The Impact of Immunosuppression

Weicheng Xu, Karin Boer, Dennis A Hesselink, Carla C Baan

BioDrugs · 2025

DOI: 10.1007/s40259-025-00713-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioDrugs, 2025. Verfasst von Weicheng Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Sector Nephrology and Transplantation, Erasmus MC Transplant Institute, University Medical Center Rotterdam Erasmus …. Hauptthemen laut MEDLINE: Extracellular Vesicles, Organ Transplantation, Immunosuppressive Agents, Graft Rejection. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent advances in extracellular vesicle (EV) research in organ transplantation have highlighted the crucial role of donor-derived EVs in triggering alloimmune responses, ultimately contributing to transplant rejection. Following transplantation, EVs carrying donor major histocompatibility complex (MHC) molecules activate recipient antigen-presenting cells (APCs), initiating both alloreactive and regulatory T-cell responses. While immunosuppressive drugs are essential for preventing rejection, they may also influence the biogenesis and release of EVs from donor cells. This review examines the impact of maintenance immunosuppressive therapy on EV biogenesis and release post-transplantation. In addition, EV release and uptake may be influenced by specific factors such as the patient's end-stage organ disease and the transplant procedure itself. In-vitro studies using primary human parenchymal and immune cells-integrated with cutting-edge multi-omics techniques, including genomics, proteomics, lipidomics, and single-EV analysis-will offer deeper insights into EV biology and the mechanisms by which immunosuppressive agents regulate EV-initiated immune processes. A detailed understanding of how organ failure, the transplantation procedure and immunosuppressive drugs affect the biology of EVs may uncover new roles for EVs in immune activation and regulation in patients, ultimately leading to improved immunosuppressive strategies and better transplant outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesOrgan TransplantationImmunosuppressive AgentsGraft RejectionImmunosuppression TherapyHumansAnimals

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Sector Nephrology and Transplantation, Erasmus MC Transplant Institute, University Medical Center Rotterdam Erasmus MC, Doctor Molewaterplein 40, Room Nc 508, 3015 GD, Rotterdam, The Net…

Zitieren

APA

Xu, W., Boer, K., Hesselink, D. A., & Baan, C. C. (2025). Extracellular Vesicles and Immune Activation in Solid Organ Transplantation: The Impact of Immunosuppression. BioDrugs. https://doi.org/10.1007/s40259-025-00713-5

Vancouver

Xu W, Boer K, Hesselink DA, Baan CC. Extracellular Vesicles and Immune Activation in Solid Organ Transplantation: The Impact of Immunosuppression. BioDrugs. 2025. doi:10.1007/s40259-025-00713-5

BibTeX
@article{Xu2025,
  author = {Xu, Weicheng and Boer, Karin and Hesselink, Dennis A and Baan, Carla C},
  title = {Extracellular Vesicles and Immune Activation in Solid Organ Transplantation: The Impact of Immunosuppression},
  journal = {BioDrugs},
  year = {2025},
  doi = {10.1007/s40259-025-00713-5}
}
Kostenlos starten →